PICO Advisory Sub-Committee – Applications considered
- 1595.1 – Closed loop upper airway stimulation for moderate to severe obstructive sleep apnoea, in patients who have failed or are intolerant to continuous positive airway pressure therapy
- 1627 – Point-of-care test for diagnosis of Neisseria gonorrhoea, Chlamydia trachomatis and Trichomonas vaginalis infection in Aboriginal and Torres Strait Islander patients presenting at health services in areas with high sexually transmitted infection burden
- 1637 – Expanded reproductive carrier screening of couples for joint carrier status of genes associated with autosomal recessive and X-linked conditions
- 1658 – Testing of tumour tissue to determine a positive homologous recombination deficiency status in women newly diagnosed with advanced (FIGO stage III-IV) high grade epithelial ovarian, fallopian tube or primary peritoneal cancer for access to PBS olaparib
- 1666 – Exclusion of the left atrial appendage via implantation of surgical epicardial clip implantation concomitant to open cardiac surgery for patients with atrial fibrillation
- 1668 – Whole body magnetic resonance imaging for detection of cancer in individuals with germline pathogenic TP53 variants
- 1669 – KRAS G12C variant testing to determine eligibility for PBS-subsidised sotorasib second-line therapy in patients with locally advanced or metastatic NSCLC
- 1671 – Targeted carrier testing for severe monogenic conditions
- 1672 – Transcatheter insertion of a leadless pacemaker
- 1673 – Single operator, single use, peroral cholangiopancreatoscopy for the diagnosis of indeterminate biliary strictures and removal of difficult biliary stones
- 1674 – Dostarlimab in mismatch repair deficient (dMMR) recurrent or advanced endometrial cancer